# PfSPZ-LARC2 Vaccine in Women of Child-bearing Potential (WOCBP) in Mali

> **NCT07675785** · PHASE2 · RECRUITING · sponsor: **Sanaria Inc.** · enrollment: 300 (estimated)

## Conditions studied

- Malaria (Plasmodium Falciparum)

## Interventions

- **BIOLOGICAL:** PfSPZ-LARC2 Vaccine
- **OTHER:** Normal Saline

## Key facts

- **NCT ID:** NCT07675785
- **Lead sponsor:** Sanaria Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-07-20
- **Primary completion:** 2028-07-15
- **Final completion:** 2030-04
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2026-07-23

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07675785

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07675785, "PfSPZ-LARC2 Vaccine in Women of Child-bearing Potential (WOCBP) in Mali". Retrieved via MORVS 2026-10-22 from https://api.morvs.ai/clinical/NCT07675785. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*